Global Pharmaceutical Rapid Microbiology Testing Market Size & Outlook
Global pharmaceutical rapid microbiology testing market, 2021-2033 (US$M)
Related Markets
Global pharmaceutical rapid microbiology testing market highlights
- The global pharmaceutical rapid microbiology testing market generated a revenue of USD 3,605.6 million in 2024 and is expected to reach USD 10,601.3 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 12.9% by 2033.
- In terms of segment, reagents & kits accounted for a revenue of USD 2,254.9 million in 2024.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 3,605.6 million |
| Market revenue in 2033 | USD 10,601.3 million |
| Growth rate | 12.9% (CAGR from 2025 to 2033) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Kits, Software, Accessories |
Other key industry trends
- In terms of revenue, the North America accounted for 39.3% of the global pharmaceutical rapid microbiology testing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 778.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Rapid Microbiology Testing Market Scope
Pharmaceutical Rapid Microbiology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott | View profile | - | - | - |
| Rapid Micro Biosystems Inc Class A | View profile | 193 | 1001 Pawtucket Boulevard West, Suite 280, Lowell, MA, United States, 01854 | https://www.rapidmicrobio.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global pharmaceutical rapid microbiology testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical rapid microbiology testing market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 62.54% in 2024. Horizon Databook has segmented the Global pharmaceutical rapid microbiology testing market based on instruments, reagents & kits, software, accessories covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Pharmaceutical Rapid Microbiology Testing Product Outlook (Revenue, USD Million, 2021-2033)
- Instruments
- Reagents & Kits
- Software
- Accessories
- Global Pharmaceutical Rapid Microbiology Testing Technology Outlook (Revenue, USD Million, 2021-2033)
- Growth-based Testing
- Nucleic Acid-based Testing
- Cellular Component-based Testing
- Viability-based Testing
- Other Techniques
- Global Pharmaceutical Rapid Microbiology Testing Application Outlook (Revenue, USD Million, 2021-2033)
- Bioburden testing
- Sterility testing
- Endotoxin testing
- Other Applications
- Environmental monitoring
- Pyrogen testing
- Mycoplasma testing
- Microbial identification
- Global Pharmaceutical Rapid Microbiology Testing Test Type Outlook (Revenue, USD Million, 2021-2033)
- Traditional/Conventional Testing
- Rapid Testing
Reasons to subscribe to Global pharmaceutical rapid microbiology testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmaceutical rapid microbiology testing market databook
-
Our clientele includes a mix of pharmaceutical rapid microbiology testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical rapid microbiology testing market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical rapid microbiology testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmaceutical rapid microbiology testing market size, by regions, 2021-2033 (US$M)
Top 10 countries: Pharmaceutical rapid microbiology testing market size, 2024 (US$M)
Global pharmaceutical rapid microbiology testing market share, by product, 2024 & 2033 (%, US$M)
Pharmaceutical rapid microbiology testing market: Opportunity assessment by country
Global pharmaceutical rapid microbiology testing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
